Pregnancy and Lupus Nephritis

Semin Nephrol. 2015 Sep;35(5):487-99. doi: 10.1016/j.semnephrol.2015.08.010.

Abstract

The management of lupus nephritis in pregnancy presents a diagnostic and therapeutic challenge for providers. Pregnancy creates a series of physiologic changes in the immune system and kidney that may result in an increased risk of disease flare and adverse maternal and fetal outcomes, such as preeclampsia, fetal loss, and preterm delivery. Conception should be delayed until disease is in remission to ensure the best pregnancy outcomes. Maternal disease activity and fetal well-being should be monitored closely by an interdisciplinary team, including obstetricians, rheumatologists, and nephrologists throughout pregnancy. Careful attention must be paid to the dosing and potential teratogenicity of medications.

Keywords: Pregnancy; anti-inflammatory agents/therapeutic use; lupus nephritis; preeclampsia; pregnancy complications; systemic lupus erythematosus.

Publication types

  • Review

MeSH terms

  • Abortion, Spontaneous / epidemiology
  • Anticoagulants / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Antiphospholipid Syndrome / drug therapy
  • Antiphospholipid Syndrome / epidemiology
  • Antiphospholipid Syndrome / immunology
  • Aspirin / therapeutic use
  • Disease Progression
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Hypertension / drug therapy
  • Immunosuppressive Agents / therapeutic use
  • Kidney / immunology*
  • Kidney / physiology
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / epidemiology
  • Lupus Erythematosus, Systemic / immunology
  • Lupus Nephritis / drug therapy
  • Lupus Nephritis / epidemiology
  • Lupus Nephritis / immunology*
  • Pre-Eclampsia / epidemiology
  • Pregnancy / immunology*
  • Pregnancy / physiology
  • Pregnancy Complications / drug therapy
  • Pregnancy Complications / epidemiology
  • Pregnancy Complications / immunology*
  • Pregnancy Outcome
  • Premature Birth / epidemiology
  • Risk Factors

Substances

  • Anticoagulants
  • Antihypertensive Agents
  • Fibrinolytic Agents
  • Immunosuppressive Agents
  • Aspirin